Make a Difference on Your Own Schedule and Terms!
All candidates should make sure to read the following job description and information carefully before applying.
Summary
The Certified Mobile Research Nurse is a Registered Nursing ad-hoc/PRN position for EmVenio Clinical Research. Our CMRN is responsible for setting appointments within the required visitation window to complete mobile visits for study participants. You’ll work cooperatively with Clinical Project Managers, Coordinators, and site personnel to complete visits and submit accurate source documentation.
We are looking for RGNs with current venepuncture and physical assessment competency to conduct visits with adult patients in their homes. The ability to drive with access to your own vehicle is a mandatory requirement for this position.
Required Qualifications
* Full NMC registration with a minimum of two (2) years of experience as a Registered Nurse (RN) and no restrictions on practice
* Two (2) years' experience in starting and performing Phlebotomy/Peripheral Blood Draw and Port access for administering infusions (date of last practice within 6 months, preferred)
* One (1) year of experience conducting full head-to-toe physical assessments, including using a stethoscope
* One (1) year of experience collecting vital signs, ECG, urine samples, and performing urine pregnancy tests
* Clean DBS
* Skilled at collecting accurate, detailed patient records including documentation of medical history and medication charting
* Excellent observational, verbal, written communication, and problem-solving skills
* Must have and maintain a current CPR certification
* Must have and maintain a current vaccination record
* Full, clean driving license with access to own vehicle
Personal Incentives
* Gain GCP training certification
* Be a member of our general staffing pool with access to multiple study opportunities
* No research experience required, on the job training provided
* Contribute to advancements of truly life changing treatments
* Supporting the same patient throughout the trial, being on the cutting-edge of developing new groundbreaking treatments for a disease with high unmet need